185 related articles for article (PubMed ID: 9476757)
21. Dysthymic disorder: clinical characteristics in relation to age at onset.
Barzega G; Maina G; Venturello S; Bogetto F
J Affect Disord; 2001 Sep; 66(1):39-46. PubMed ID: 11532531
[TBL] [Abstract][Full Text] [Related]
22. Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study.
Klein DN; Schwartz JE; Rose S; Leader JB
Am J Psychiatry; 2000 Jun; 157(6):931-9. PubMed ID: 10831473
[TBL] [Abstract][Full Text] [Related]
23. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.
Williams JW; Barrett J; Oxman T; Frank E; Katon W; Sullivan M; Cornell J; Sengupta A
JAMA; 2000 Sep; 284(12):1519-26. PubMed ID: 11000645
[TBL] [Abstract][Full Text] [Related]
24. Differences in the clinical characteristics of adolescent depressive disorders.
Karlsson L; Pelkonen M; Heilä H; Holi M; Kiviruusu O; Tuisku V; Ruuttu T; Marttunen M
Depress Anxiety; 2007; 24(6):421-32. PubMed ID: 17051545
[TBL] [Abstract][Full Text] [Related]
25. ADad 7: Relationship between depression and Anxiety Disorders among adolescents in a rural community population in India.
Russell PS; Nair MK; Shankar SR; Tsheringla S; Jakati PK; Chembagam N; Nazeema S
Indian J Pediatr; 2013 Nov; 80 Suppl 2():S165-70. PubMed ID: 24062271
[TBL] [Abstract][Full Text] [Related]
26. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
[TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory chronic depression and dysthymia with high-dose thyroxine.
Rudas S; Schmitz M; Pichler P; Baumgartner A
Biol Psychiatry; 1999 Jan; 45(2):229-33. PubMed ID: 9951571
[TBL] [Abstract][Full Text] [Related]
28. Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study.
Maia AC; Braga Ade A; Paes F; Machado S; Nardi AE; Silva AC
Rev Assoc Med Bras (1992); 2014; 60(1):59-62. PubMed ID: 24918854
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the clinical characteristics of Chinese patients with recurrent major depressive disorder with and without dysthymia.
Sang W; Li Y; Su L; Yang F; Wu W; Shang X; Zhang G; Shen J; Sun M; Guo L; Li Z; Yan L; Zhang B; Wang G; Liu G; Liu T; Zhang J; Wang Y; Yu B; Pan J; Li Y; Hu C; Yang L; Huang Y; Xie S; Wang X; Liu J; Lv L; Chen Y; Zhang L; Dang Y; Shi S; Chen Y; Kendler KS; Flint J; Li K
J Affect Disord; 2011 Dec; 135(1-3):106-10. PubMed ID: 21824660
[TBL] [Abstract][Full Text] [Related]
30. [Depressive disorders in diabetic patients].
Manoudi F; Chagh R; Benhima I; Asri F; Diouri A; Tazi I
Encephale; 2012 Oct; 38(5):404-10. PubMed ID: 23062454
[TBL] [Abstract][Full Text] [Related]
31. The effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression.
Kim KH; Lee SM; Paik JW; Kim NS
J Affect Disord; 2011 Jul; 132(1-2):121-9. PubMed ID: 21402412
[TBL] [Abstract][Full Text] [Related]
32. Childhood adversity and anxiety versus dysthymia co-morbidity in major depression.
Harkness KL; Wildes JE
Psychol Med; 2002 Oct; 32(7):1239-49. PubMed ID: 12420893
[TBL] [Abstract][Full Text] [Related]
33. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
[TBL] [Abstract][Full Text] [Related]
34. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
35. Three-year follow-up of women with the sole diagnosis of depressive personality disorder: subsequent development of dysthymia and major depression.
Kwon JS; Kim YM; Chang CG; Park BJ; Kim L; Yoon DJ; Han WS; Lee HJ; Lyoo IK
Am J Psychiatry; 2000 Dec; 157(12):1966-72. PubMed ID: 11097962
[TBL] [Abstract][Full Text] [Related]
36. An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia.
Orr G; Seidman SN; Weiser M; Gershon AA; Dubrov Y; Klein DF
J Nerv Ment Dis; 2008 Jun; 196(6):496-500. PubMed ID: 18552628
[TBL] [Abstract][Full Text] [Related]
37. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
39. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
40. Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.
McCullough JP; Klein DN; Keller MB; Holzer CE; Davis SM; Kornstein SG; Howland RH; Thase ME; Harrison WM
J Abnorm Psychol; 2000 Aug; 109(3):419-27. PubMed ID: 11016111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
